Cargando…
Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals
OBJECTIVE: To identify the number of cumulative medication exposures and most frequently used medications in infants with severe BPD. STUDY DESIGN: We performed a retrospective cohort study in infants with severe BPD admitted to United States children’s hospitals. We measured cumulative medication e...
Autores principales: | Bamat, Nicolas A., Kirpalani, Haresh, Feudtner, Chris, Jensen, Erik A., Laughon, Matthew M., Zhang, Huayan, Monk, Heather M., Passarella, Molly, Lorch, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713592/ https://www.ncbi.nlm.nih.gov/pubmed/31227785 http://dx.doi.org/10.1038/s41372-019-0415-9 |
Ejemplares similares
-
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
por: Jensen, Erik A., et al.
Publicado: (2019) -
State of the Art Review: Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants
por: Foglia, Elizabeth E., et al.
Publicado: (2017) -
Alarm Burden in Infants With Bronchopulmonary Dysplasia Monitored With Pulse Oximetry at Home
por: Herrick, Heidi M., et al.
Publicado: (2022) -
Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants
por: Jensen, Erik A., et al.
Publicado: (2023) -
In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017)